Tesirine (SG3249) is a drug-linker conjugates for ADC which is used in the treatment of several cancers. PBD Dimer is a DNA alkylating which inhibits DNA replication.
Structure of 1595275-62-9
* For research and manufacturing use only. We do not sell to patients.
Size | Price | Stock | Quantity |
---|---|---|---|
-- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
NCT Number | Condition Or Disease | Phase | Start Date | Sponsor | Status |
---|---|---|---|---|---|
NCT04699461 | Relapsed Follicular Lymphoma | Phase 2 | 2021-11-15 | ADC Therapeutics S.A. | Recruiting |
NCT03589469 | Diffuse Large B-Cell Lymphoma Refractory | Phase 2 | 2021-07-29 | ADC Therapeutics S.A. | Active, not recruiting |
NCT03684694 | Diffuse Large B-Cell Lymphoma | Phase 1, Phase 2 | 2021-10-15 | ADC Therapeutics S.A. | Recruiting |
NCT04974996 | Diffuse Large B-Cell Lymphoma | Phase 1 | 2021-10-18 | ADC Therapeutics S.A. | Not yet recruiting |
NCT03543358 | Cancer | Phase 2 | 2021-01-05 | AbbVie | Completed |
Catalog | Product Name | CAS | Inquiry |
---|---|---|---|
BADC-01608 | Loncastuximab tesirine | 1879918-31-6 |
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.